With a number of new legislators and new governors sworn in this month, 2019 promises to be an exciting year for state-level rheumatology advocacy.
Also by this Author
“Now is the time to reach out and share our top issues with new legislators in your state,” suggests Joseph Cantrell, ACR senior manager of state affairs.
ACR Affiliate Society Council Chair Christopher Adams, MD, FACP, FACR, works with Mr. Cantrell to support state rheumatology societies in working with legislators to promote policies that enhance rheumatology care for providers and patients. Mr. Cantrell and Dr. Adams shared five key legislative priority areas the ACR will be supporting at the state level in the year ahead.
- Pharmacy benefit manager (PBM) reform—The ACR will continue to raise awareness about the role PBMs play in drug pricing, and promote legislation that increases transparency of PBM practices and provides more oversight of PBMs by state governments.
“We expect to see many states introduce PBM legislation, with more states moving to bring PBMs under the regulatory authority of the insurance commissioner,” Mr. Cantrell says.